miR-134 Functions as a Tumor Suppressor in Cell Proliferation and Epithelial-to-Mesenchymal Transition by Targeting KRAS in Renal Cell Carcinoma Cells
Authors:
- 1 June 2015
- journal article
- research article
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 34 (6) , 429-436
Abstract
Aberrant microRNAs (miRNAs) are reported to contribute to the pathogenesis of most human malignancies. The miRNA, miR-134, has been found to be downregulated in renal cell carcinoma (RCC), but its function in the disease is unknown. The aims of this study were to detect the expression of miR-134 in human RCC samples and explore its function in RCC cell lines. Real-time qualitative polymerase chain reaction (qPCR) was used to quantify miR-134 in human RCC samples. Assays for cell cycle, viability, migration, and invasion were performed to assess the phenotypic changes in RCC cells. A luciferase reporter assay was carried out to confirm whether KRAS (Kirsten rat sarcoma viral oncogene homolog) is a direct target of miR-134. Western blot was used to identify the potential signaling pathways that had an impact on RCC cell growth and alterations of markers for epithelial–mesenchymal transition (EMT), which affected metastasis by miR-134. miR-134 was found to be downregulated in RCC samples (ppppp<0.05) by blocking EMT in RCC cell lines. KRAS was identified as a target of miR-134, and miR-134 may act as a tumor suppressor through the KRAS-related MAPK/ERK pathway other than PI3K/AKT signaling. Thus, miR-134 may function as a tumor suppressor in cell proliferation and EMT by targeting KRAS in RCC cells.Keywords
This publication has 28 references indexed in Scilit:
- miR‐134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non‐small cell lung cancer cellsFEBS Letters, 2012
- K-Ras and B-Raf oncogenes inhibit colon epithelial polarity establishment through up-regulation of c-mycJournal of Cell Biology, 2012
- MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2Journal of Cancer Research and Clinical Oncology, 2011
- miRNA Profiling for Clear Cell Renal Cell Carcinoma: Biomarker Discovery and Identification of Potential Controls and Consequences of miRNA DysregulationJournal of Urology, 2011
- MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic ReviewEuropean Urology, 2011
- Metastasis: new perspectives on an old problemMolecular Cancer, 2011
- MicroRNAs, cancer and cancer stem cellsCancer Letters, 2011
- Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissuesJournal of Cancer Research and Clinical Oncology, 2009
- Causes and consequences of microRNA dysregulation in cancerNature Reviews Genetics, 2009
- Widespread deregulation of microRNA expression in human prostate cancerOncogene, 2007